Navigation Links
LCA Hails International Investigators Studying Lung Cancer
Date:9/4/2007

Recommendations to Help Doctors and Patients More Precisely Stage, Diagnose

and Treat Lung Cancer

SEOUL, South Korea, Sept. 4 /PRNewswire-USNewswire/ -- Lung Cancer Alliance (LCA), the only US-based organization devoted exclusively to patient support and advocacy for those living with or at risk for lung cancer, hailed today's presentation by lead investigators of the International Association for the Study of Lung Cancer (IASLC) at the 12th World Conference on Lung Cancer (WCLC), as a significant development in how doctors and patients will more precisely stage, diagnose and treat lung cancer.

Every seven years international staging guidelines undergo a reevaluation to determine whether changes need to be made to the staging classification system. This is important because precise staging will provide clinicians with a common basis for the selection of the clinical management to minimize possible side effects while optimizing the chance of a favorable outcome for patients.

The IASLC study, which collected data on more than 100,000 patients worldwide, confirmed that in the last decade improvements in understanding tumor characteristics, emergence of new anti-cancer therapy and advancements in technology, particularly CT and PET scans, have allowed for a more precise analysis of tumor (T), lymph node (N) and metastasis (M) descriptors that make up the lung cancer staging system.

"Patients diagnosed with lung cancer will now benefit from a more accurate assessment of their disease, its staging and treatment protocols", said Laurie Fenton Ambrose, President of Lung Cancer Alliance. "By continuing to refine our knowledge -- we will more positively impact patient outcomes. I applaud IASLC for significant contribution in this area."

The IASLC study recommendations are due to be implemented in 2009 upon publication by the International Union Against Cancer and the American Joint Committee on Cancer.

Patients will not be negatively impacted by this reclassification.

Lung Cancer Alliance (http://www.LungCancerAlliance.org) is the only national non-profit organization solely dedicated to patient support and advocacy for people living with, or at risk for, lung cancer. As the number one cancer killer, lung cancer will kill more than 160,000 Americans and 1 million people worldwide this year alone.


'/>"/>
SOURCE Lung Cancer Alliance
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. LCA Hails Congressional Front Against Pink Camel Cigarette Campaign
2. PETA Hails McCartney for Boycotting Animal-testing Charities
3. International community warns India on HIV situation
4. Key step forward on International Health Rules
5. ICMR along with other International Research organisation with drug development for Neglected Diseases
6. International Osteoporosis Research Centre To Be Started In India.
7. Indian hospitals require International Accreditation
8. International Conference On Malaria - Laveran To Genomics
9. Delhi To Host International Women’s Congress From Nov 2
10. International conference on Ayurveda to be held on Kerala
11. International Teleradiology: The Future Of Radiologic Diagnosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... services business of UnitedHealth Group (NYSE: UNH), has made a multi-million dollar partnership ... affected by post-traumatic stress disorder (PTSD) and traumatic brain injuries (TBI) over the ...
(Date:8/20/2017)... ... ... Are you an adult with gluten intolerance or Celiac disease living with ... participating in a research study that focuses on family interactions when dealing with dietary ... aspects of adults who have gluten sensitivities who cohabitate with other adults who may ...
(Date:8/19/2017)... , ... August 19, 2017 , ... ... that it is the first organization with pending recognition status from the Centers ... Program (“DPP”) via group telehealth classes and live video conferencing. , The ...
(Date:8/19/2017)... ... August 19, 2017 , ... ... joined its Orlando location as an interventional pain management physician. He brings a ... the treatment of migraine headaches, and significant experience in spinal cord stimulation for ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... International, LLC (“Quick”), a highly specialized asset-light logistics provider of complex transport ... a definitive agreement to purchase Unitrans International Corporation, a division of Roadrunner ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... , July 26, 2017 E.I. Medical Imaging ... the Bimini SharkLab to custom design the worlds first ultrasound system ... sharks in their native habitat. In preparation for a ... Channel,s Shark Week, Dr. Guttridge approached EIMI with the ... diagnosis directly to hammerhead sharks underwater. ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 /PRNewswire/ ... drugs to treat rare nervous system diseases, has concluded a ... and market the drug SOM0226 against transthyretin amyloidosis (ATTR). Before ... promising results in a Phase 2 study conducted in ... in the United States ...
Breaking Medicine Technology: